4Lun·

BionTech sell-off triggered by resignation / dismissal of Dr. Peter Marks

$BNTX (-4,36 %) has taken quite a beating in pre-market trading today. R.F. Kennedy and Peter Marks (FDA) have parted ways following differences of opinion on the subject of vaccinations. The vaccine values such as $BNTX (-4,36 %) and $MRNA (-5,39 %) have suffered. For me, this is a good opportunity to add to my BionTech position right after the US IPO - I am speculating on a breakthrough in the oncology pipeline in 2026. Biontech is one of my long term swings.

In addition to Biontech, I also added to my $RDC (-1,66 %) Shopapotheke position again today.

31.03

BioNTech SE ADR

Compró 15 a 80,05 €

1200,75 €

11 Comentarios

mami_goes_boerse@mami_goes_boerse

4Lun

This will be a kind of "ultraswing" on the timeline 😅 Keep your fingers crossed ✊

•

Soprano@Soprano

4Lun

Even as a healthcare investor, I consider the trade to be a casino

••

Ver todas las 5 respuestas adicionales

Usuario eliminado

4Lun

Comentario eliminado

TomTurboInvest@TomTurboInvest

4Lun

@Nobody_123 I've been reading up since the corona period. I've read a lot about the decades of research into mRNA. They are one of the few individual stocks in the children's portfolios, but I don't want to claim that I understand biotechnology. I have doctors in my circle of acquaintances who are convinced of the revolution that mRNA is supposed to bring. But at the end of the day, these are just opinions.
But I do follow the study reports from BioNTech, even if I don't understand the details 😅
What I like is the cash position, which allows them to continue working at full throttle on research. Ultimately, I trust that they will succeed.

••

Usuario eliminado

4Lun

Comentario eliminado

TomTurboInvest@TomTurboInvest

4Lun

@Nobody_123 We entered the market in a similar way, and I got out at over €300 on the return. But then I got back in too early. I now have a buy-in of around €94 thanks to a few additional purchases

••